Synopsis
The purpose of this study is to help patients improve endocrine therapy compliance, and assess the best method of improving endocrine therapy compliance (text message reminder, motivational interviewing counseling, a combination of both or enhanced usual care)
Eligibility Criteria
Stg I-III, Hormone Receptor-positive, HER2-Negative breast cancer who have completed chemo/radiation/surgery and recently started or will start Endocrine Therapy (ie. Anastrozole, Tamoxifen, Exemestane, Letrozole etc).
Learn more about the A191901 trail or call the Phoenixville Hospital Clinical Research Office at 610-983-1811.
